Nivomab Injection 40 mg/4 ml contains Nivolumab, a monoclonal antibody belonging to the immune checkpoint inhibitor class. It is used in oncology to help the immune system recognize and attack cancer cells. Nivolumab works by targeting the PD-1 receptor, enhancing the body’s natural anti-cancer immune response. It is used in the treatment of several advanced and metastatic cancers under specialist supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Nivolumab
• Strength: 40 mg per 4 ml vial

Mechanism of Action

Nivolumab is a programmed death-1 (PD-1) immune checkpoint inhibitor. Cancer cells often evade immune detection by activating PD-1 pathways that suppress immune response. By blocking PD-1 receptors on T-cells, Nivolumab restores immune activity, allowing the body’s immune system to recognize and destroy cancer cells more effectively.

Indications

Nivomab Injection is indicated for the treatment of:

• Metastatic melanoma
• Non-small cell lung cancer (NSCLC)
• Renal cell carcinoma (kidney cancer)
• Classical Hodgkin lymphoma
• Head and neck squamous cell carcinoma
• Other cancers as determined by an oncologist

Dosage and Administration

• Administered intravenously by a healthcare professional only
• Dosage and frequency depend on cancer type, body weight, and treatment protocol
• Given as an infusion over a specified period in a clinical setting
• Treatment is continued based on response and tolerability

Benefits

• Enhances immune system’s ability to fight cancer
• Provides targeted therapy with durable responses in certain cancers
• Used in multiple advanced-stage malignancies
• Offers an innovative immunotherapy approach

Possible Side Effects

Nivolumab may cause immune-related side effects due to increased immune activity, including:

• Fatigue
• Skin rash or itching
• Diarrhea or colitis
• Liver inflammation (hepatitis)
• Lung inflammation (pneumonitis)
• Endocrine disorders (thyroid or adrenal issues)

Serious immune reactions may occur and require immediate medical intervention.

Precautions and Warnings

• Must be administered only under supervision of an oncology specialist
• Regular monitoring of liver, kidney, and thyroid function is required
• Use with caution in patients with autoimmune disorders
• Not recommended during pregnancy or breastfeeding
• Immediate reporting of unusual symptoms is essential

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store in a refrigerator as per manufacturer guidelines (2°C to 8°C)
• Do not freeze
• Protect from light
• Keep out of reach of children

Conclusion

Nivomab Injection 40 mg/4 ml (Nivolumab) is a modern immunotherapy agent that helps activate the body’s immune system to fight cancer. It plays an important role in the treatment of various advanced malignancies and is used strictly under specialist oncology supervision for optimal safety and effectiveness.